Etoposide
Etoposide Injection, USP
Approved
Approval ID
fe870629-104d-4d67-a7c6-f53bc588121e
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 2, 2022
Manufacturers
FDA
Fresenius Kabi USA, LLC
DUNS: 608775388
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ETOPOSIDE
PRODUCT DETAILS
NDC Product Code63323-104
Application NumberANDA074983
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateJune 2, 2022
Generic NameETOPOSIDE
INGREDIENTS (6)
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
POLYETHYLENE GLYCOL 300Inactive
Code: 5655G9Y8AQ
Classification: IACT
ETOPOSIDEActive
Quantity: 20 mg in 1 mL
Code: 6PLQ3CP4P3
Classification: ACTIB
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT